Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) is -28.81% lower on its value in year-to-date trading and has touched a low of $12.51 and a high of $22.80 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TEVA stock was last observed hovering at around $16.00 in the last trading session, with the day’s loss setting it -0.31%.
Currently trading at $15.69, the stock is -5.80% and -19.02% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 14.6 million and changing -1.94% at the moment leaves the stock -12.20% off its SMA200. TEVA registered 19.32% gain for a year compared to 6-month loss of -16.23%.
The stock witnessed a -11.51% gain in the last 1 month and extending the period to 3 months gives it a -5.31%, and is -5.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.75% over the week and 3.38% over the month.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has around 36167 employees, a market worth around $17.98B and $16.53B in sales. Fwd P/E is 5.66. Profit margin for the company is -9.91%. Distance from 52-week low is 25.42% and -31.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-7.56%).
with sales reaching $4B over the same period.The EPS is expected to grow by 2.39% this year, but quarterly earnings will post 3.53% year-over-year. Quarterly sales are estimated to grow 4.68% in year-over-year returns.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Top Institutional Holders
The shares outstanding are 1.15B, and float is at 1.15B with Short Float at 2.33%.
The top institutional shareholder in the company is BLACKROCK INC. with over 42.99 million shares valued at $698.55 million. The investor’s holdings represent 3.8279% of the TEVA Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 41.98 million shares valued at $$682.15 million to account for 3.7381 of the shares outstanding. The other top investors are ION ASSET MANAGEMENT LTD. which holds 36.33 million shares representing 3.2065% and valued at over $590.36 million, while CLAL INSURANCE ENTERPRISES HOLDINGS LTD holds 2.8543 of the shares totaling 32.34 million with a market value of $525.67 million.
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Insider Activity
A total of 0 insider transactions have happened at Teva- Pharmaceutical Industries Ltd. ADR (TEVA) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Still, SEC filings show that on Mar 04 ’25, Hughes Eric A (Officer) Proposed Sale 23,251 shares at an average price of $16.00 for $0.37 million. The insider now directly holds shares of Teva- Pharmaceutical Industries Ltd. ADR (TEVA).
Teva- Pharmaceutical Industries Ltd. ADR (TEVA): Who are the competitors?
The company’s main competitors (and peers) include AstraZeneca PLC ADR (AZN) that is trading 18.35% up over the past 12 months. Sanofi ADR (SNY) that is 21.02% higher over the same period.
